The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...
At this year's ASH congress, the results of the phase 1b/2 DURGA-1 of AZD0120 – a dual BCMA and CD19-directed CAR-T therapy – ...
Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to ...
AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...
The move would onshore production of its rare disease products at an existing facility in Frederick and build a clinical ...
The pharmaceutical company AstraZeneca can move forward with an addition to one of the buildings on its Frederick campus, ...
AstraZeneca's baxdrostat heads into FDA review after Phase 3 data showed strong blood pressure reductions in adults with hard ...
Home to 4.8 billion people or 60 percent of the world’s population, Asia accounts for 50 percent of the global cancer ...
In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...
AstraZeneca PLC (NASDAQ:AZN) is one of the best pharma stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) received a rating ...
A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to ...
The Hechinger Report on MSN
The US wants more apprenticeships. The UK figured out how to make them coveted roles
England has embraced degree apprenticeship as a solution to a wide range of challenges, including high youth unemployment, spiraling student debt and rapid technological change. The programs have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback